Drug: omalizumab Quarter: 2016Q3
Total Drug/Injury Combinations: 175 Number of Pages: 9
DRUGNAME | PT | EventCount | |
---|---|---|---|
Omalizumab | Maternal exposure during pregnancy | 51 | view events |
Omalizumab | Upper respiratory tract infection | 40 | view events |
Omalizumab | Anaphylactic reaction | 38 | view events |
Omalizumab | Asthma | 34 | view events |
Omalizumab | Pneumonia | 33 | view events |
Omalizumab | Nasopharyngitis | 29 | view events |
Omalizumab | Malaise | 27 | view events |
Omalizumab | Weight increased | 25 | view events |
Omalizumab | Headache | 23 | view events |
Omalizumab | Pyrexia | 23 | view events |
Omalizumab | Blood pressure decreased | 22 | view events |
Omalizumab | Migraine | 19 | view events |
Omalizumab | Oedema | 19 | view events |
Omalizumab | Pain in extremity | 19 | view events |
Omalizumab | Somnolence | 19 | view events |
Omalizumab | Urinary tract infection | 19 | view events |
Omalizumab | Acne | 18 | view events |
Omalizumab | Adverse drug reaction | 18 | view events |
Omalizumab | Asthenia | 18 | view events |
Omalizumab | Blood pressure increased | 18 | view events |
Total Drug/Injury Combinations: 175 Number of Pages: 9
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)